Research & Innovation Information Centre
Tick (check) box to add article to PDF "basket"
EU-funded researchers have developed three new tools to kill malaria-carrying mosquitoes. They are now working to bring their low-cost innovations to market quickly - a boost to the global battle against this deadly disease.
Published: 21 October 2014
European scientists have developed a revolutionary new ultrasound device capable of identifying patients at imminent risk of a heart attack or stroke. The technique, which is the subject of a patent application, was developed by the SUMMIT project, which is supported by the Innovative Medicines Initiative (IMI).
Published: 2 September 2014
Type 1 diabetes results from abnormal activity of the body's immune system and it is on the rise in European children and adolescents. A European research project aims to find out why the cleanliness long assumed to be the best defence against this disease could actually be the cause of it.
Published: 20 August 2014
Despite many scientific breakthroughs over the years, cancer remains a deadly disease, and treatments are often limited in their scope. But cancer research is improving and one of the most promising areas is in biological therapy, or biotherapy, where a €100 million loan from the European Investment Bank (EIB) with financial backing from the European Union is helping find out how to manage molecules to kill cancer cells while sparing their healthy neighbours.
Published: 14 August 2014
Understanding the cell changes associated with cancer will provide vital clues for both detecting and treating the disease. The EU-funded GlycoBioM project is contributing with tools to pinpoint disease indicators. And three years into the project, the team has already come up with a method to reduce false-positive cancer diagnoses.
Published: 7 August 2014
New tumour profiling methods developed by EU-funded researchers aim to help doctors adjust treatments for colorectal cancer to the specific needs of an individual patient. The methods are currently at the trial stage and could be in use in clinics within three years.
Published: 29 July 2014
The European FP7 project DeCanbio brought together a consortium of clinicians and researchers in genomics, proteomics and bioinformatics to identify and validate biomarkers that hint at a recurring bladder cancer. The Centre de Recherche de la Santé (CRP-Santé) joined forces with researchers and clinicians from France, Spain, Greece, Switzerland, and Germany to develop a simple test to spot this.
Published: 25 July 2014
Children rarely develop tumours, but if they do, the prognosis is uncertain. Sometimes, the growth just disappears, without therapy. Unfortunately, few families are so lucky, and there are only a handful of specifically developed treatments. The EU-funded ASSET project is finding better ways to tackle some of the cancers that can appear in early life.
Published: 23 June 2014
A more powerful mass spectrometer developed by EU-funded researchers could potentially lead to better treatments for patients with degenerative brain diseases such as Alzheimer's and Parkinson's. In recent years, mapping the human genome has led to unparalleled insight into genes the body's blueprint.
Published: 27 May 2014
Cirrhosis, liver failure and liver cancer are just some of the many life-threatening conditions caused by the Hepatitis C Virus (HCV). Unlike Hepatitis A and B there is no vaccine, and although new treatments for HCV are more effective, they still have harmful side effects.
Published: 23 May 2014